Pharmaceuticals

Four times a year, five teams of scientists are invited to Israel for a five-day intensive boot camp, during which they solve a challenge relevant to today’s pharma industry.

CytoReason’s massive database and AI-led platform, biotech companies can identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval.

Grotto also helped in national strategy developments during the coronavirus outbreak in Israel for the first time.

The FTC and seven states, including New York, sued in January 2020 accusing Vyera Pharmaceuticals — formerly Shkreli’s company Turing — of increasing the price of Daraprim by more than 4,000%.

Arena's shares soared on the news. They ended trading Friday $49.94 but closed on Monday at $90.08 — an 80 percent gain. Pfizer's shares also were up nearly 5 percent.

Most women suffer greatly from premenstrual syndrome (PMS) and yet, to this day, there hasn’t been a good solution to this suffering.

The lawsuit was originally filed in April, when several California counties accused drugmakers of fueling America's opioid crisis.

Quris, an artificial intelligence (AI) company operating in the pharmaceutical space, launched this week and announced a $9 million in seed funding.

A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.

Tay-Sachs is an inherited disorder that is almost always fatal and disproportionately affects Ashkenazi Jews. Currently, there is no viable medical treatment available.